Marinella Clerico Clinical and Biological Sciences Department, Neurology Unit University of Torino, San Luigi Gonzaga Hospital Biography Publications Institution JoVE Articles Marinella Clerico has not added a biography. If you are Marinella Clerico and would like to personalize this page please email our Author Liaison for assistance. Publications Influence of Cigarette Smoking on ALS Outcome: a Population-based Study Journal of Neurology, Neurosurgery, and Psychiatry. Nov, 2016 | Pubmed ID: 27656044 Long-term Adherence of Patients with Relapsing-remitting Multiple Sclerosis to Subcutaneous Self-injections of Interferon β-1a Using an Electronic Device: the RIVER Study Expert Opinion on Drug Delivery. Jul, 2016 | Pubmed ID: 26909646 Alemtuzumab Long-term Immunologic Effect: Treg Suppressor Function Increases Up to 24 Months Neurology(R) Neuroimmunology & Neuroinflammation. Feb, 2016 | Pubmed ID: 26819963 Long-term Follow-up of Ultrasound-guided Botulinum Toxin-A Injections for Sialorrhea in Neurological Dysphagia Journal of Neurology. Dec, 2015 | Pubmed ID: 26410746 Epigenetic Therapy for Friedreich Ataxia Annals of Neurology. Oct, 2014 | Pubmed ID: 25159818 Th22 Cells Are Expanded in Multiple Sclerosis and Are Resistant to IFN-β Journal of Leukocyte Biology. Dec, 2014 | Pubmed ID: 25097195 Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine: a Population-based Study JAMA Neurology. Sep, 2014 | Pubmed ID: 25048026 Treatment of Relapsing-remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence from an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study) JAMA Neurology. Aug, 2014 | Pubmed ID: 24977406 Patient Adherence to and Tolerability of Self-administered Interferon β-1a Using an Electronic Autoinjection Device: a Multicentre, Open-label, Phase IV Study BMC Neurology. Mar, 2012 | Pubmed ID: 22390218 Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 Journal of Immunology (Baltimore, Md. : 1950). Feb, 2012 | Pubmed ID: 22219326 Pro-inflammatory Cytokine and Chemokine MRNA Blood Level in Multiple Sclerosis is Related to Treatment Response and Interferon-beta Dose Journal of Neuroimmunology. Sep, 2010 | Pubmed ID: 20573405 T-helper 17 Cells Expand in Multiple Sclerosis and Are Inhibited by Interferon-beta Annals of Neurology. May, 2009 | Pubmed ID: 19475668 Risk Factors for Tumor Occurrence in Patients with Myasthenia Gravis Journal of Neurology. Aug, 2009 | Pubmed ID: 19330280 The OPTimization of Interferon for MS Study: 375 Microg Interferon Beta-1b in Suboptimal Responders Journal of Neurology. Sep, 2008 | Pubmed ID: 18825438 The Therapy of Multiple Sclerosis with Immune-modulating or Immunosuppressive Drug. A Critical Evaluation Based Upon Evidence Based Parameters and Published Systematic Reviews Clinical Neurology and Neurosurgery. Nov, 2008 | Pubmed ID: 18164542 Adherence to Interferon-beta Treatment and Results of Therapy Switching Journal of the Neurological Sciences. Aug, 2007 | Pubmed ID: 17376486 Interferon-beta1a for the Treatment of Multiple Sclerosis Expert Opinion on Biological Therapy. Apr, 2007 | Pubmed ID: 17373904 A Randomized Study of Two Interferon-beta Treatments in Relapsing-remitting Multiple Sclerosis Neurology. Dec, 2006 | Pubmed ID: 17190964 The Importance of Maintaining Effective Therapy in Multiple Sclerosis Journal of Neurology. Sep, 2005 | Pubmed ID: 16170500 High-dose, Frequently Administered Interferon Beta Therapy for Relapsing-remitting Multiple Sclerosis Must Be Maintained over the Long Term: the Interferon Beta Dose-reduction Study Journal of the Neurological Sciences. Jul, 2004 | Pubmed ID: 15240190 Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea Pierangelo Barbero1, Marco Busso2, Carlo Alberto Artusi1, Stefania De Mercanti1, Marco Tinivella3, Andrea Veltri2, Luca Durelli1, Marinella Clerico1 1Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital, 2Oncology Department, Radiology Unit, University of Torino, San Luigi Gonzaga Hospital, 3Clinical and Biological Sciences Department, Dietologic and Nutrition Unit, University of Torino, San Luigi Gonzaga Hospital JoVE 54606 Medicine
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea Pierangelo Barbero1, Marco Busso2, Carlo Alberto Artusi1, Stefania De Mercanti1, Marco Tinivella3, Andrea Veltri2, Luca Durelli1, Marinella Clerico1 1Clinical and Biological Sciences Department, Neurology Unit, University of Torino, San Luigi Gonzaga Hospital, 2Oncology Department, Radiology Unit, University of Torino, San Luigi Gonzaga Hospital, 3Clinical and Biological Sciences Department, Dietologic and Nutrition Unit, University of Torino, San Luigi Gonzaga Hospital JoVE 54606 Medicine
